MAPT and Parkinson disease: (III) Associations between inflammatory markers with CSF levels of neurodegenerative/PD-biomarkers are primarily seen with t-Tau, p-Tau and α-synuclein but not with Aβ1−42 and are more robust for CSF than for serum.